Home
/
MESA LABORATORIES INC /CO/
/
Financials
/
Quarterly
MESA LABORATORIES INC /CO/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that MESA LABORATORIES INC /CO/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
$65.13M
Feb 3, 2026
Q2
2025
Sep 30, 2025
$60.74M
Nov 6, 2025
Q1
2025
Jun 30, 2025
$59.54M
Aug 5, 2025
Q3
2025
Dec 31, 2024
$62.84M
Feb 3, 2026
Q2
2025
Sep 30, 2024
$57.83M
Nov 6, 2025
Q1
2025
Jun 30, 2024
$58.17M
Aug 5, 2025
Q3
2025
Dec 31, 2023
$53.47M
Feb 4, 2025
Q2
2025
Sep 30, 2023
$53.17M
Nov 7, 2024
Q1
2025
Jun 30, 2023
$50.65M
Aug 5, 2024
Q3
2024
Dec 31, 2022
$54.29M
Feb 5, 2024
Q2
2024
Sep 30, 2022
$58.75M
Nov 6, 2023
Q1
2024
Jun 30, 2022
$50.45M
Aug 3, 2023
Q3
2023
Dec 31, 2021
$54.70M
Feb 6, 2023
Q2
2023
Sep 30, 2021
$35.84M
Nov 3, 2022
Q1
2023
Jun 30, 2021
$34.92M
Aug 4, 2022
Q3
2022
Dec 31, 2020
$34.17M
Feb 3, 2022
Q2
2022
Sep 30, 2020
$31.86M
Nov 4, 2021
Q1
2022
Jun 30, 2020
$29.94M
Aug 5, 2021
Q3
2020
Dec 31, 2019
$31.66M
Feb 3, 2021
Q2
2020
Sep 30, 2019
$25.54M
Nov 5, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Dec 31, 2017
$23.67M
Feb 6, 2018
Q2
2018
Sep 30, 2017
$22.95M
Nov 6, 2017
Q1
2018
Jun 30, 2017
$22.67M
Aug 1, 2017
Q3
2018
Dec 31, 2016
$23.84M
Feb 6, 2018
Q2
2018
Sep 30, 2016
$24.41M
Nov 6, 2017
Q1
2018
Jun 30, 2016
$21.11M
Aug 1, 2017
Q3
2017
Dec 31, 2015
$19.91M
Feb 6, 2017
Q2
2017
Sep 30, 2015
$21.78M
Nov 7, 2016
Q1
2017
Jun 30, 2015
$18.16M
Aug 1, 2016
Q3
2016
Dec 31, 2014
$17.83M
Feb 4, 2016
Q2
2016
Sep 30, 2014
$18.54M
Nov 4, 2015
Q1
2016
Jun 30, 2014
$16.40M
Aug 4, 2015
Q3
2015
Dec 31, 2013
$13.12M
Feb 2, 2015
Q2
2015
Sep 30, 2013
$12.68M
Nov 6, 2014
Q1
2015
Jun 30, 2013
$11.22M
Aug 6, 2014
Q3
2013
Dec 31, 2012
$11.36M
Feb 5, 2014
Q2
2013
Sep 30, 2012
$11.71M
Nov 5, 2013
Q1
2013
Jun 30, 2012
$10.56M
Aug 7, 2013
Q3
2011
Dec 31, 2011
$9.26M
Feb 10, 2012
Q3
2011
Dec 31, 2010
$7.65M
Feb 10, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
$3.63M
Feb 3, 2026
Q3
2025
Sep 30, 2025
$2.48M
Feb 3, 2026
Q2
2025
Sep 30, 2025
$2.48M
Nov 6, 2025
Q1
2025
Jun 30, 2025
$4.74M
Aug 5, 2025
Q3
2025
Jun 30, 2025
$4.74M
Feb 3, 2026
Q2
2025
Jun 30, 2025
$4.74M
Nov 6, 2025
Q3
2025
Dec 31, 2024
($1.68M)
Feb 3, 2026
Q3
2025
Sep 30, 2024
$3.43M
Feb 3, 2026
Q2
2025
Sep 30, 2024
$3.43M
Nov 6, 2025
Q1
2025
Jun 30, 2024
$3.39M
Aug 5, 2025
Q3
2025
Jun 30, 2024
$3.39M
Feb 3, 2026
Q2
2025
Jun 30, 2024
$3.39M
Nov 6, 2025
Q3
2025
Dec 31, 2023
$2.12M
Feb 4, 2025
Q3
2025
Sep 30, 2023
($1.23M)
Feb 4, 2025
Q2
2025
Sep 30, 2023
($1.23M)
Nov 7, 2024
Q1
2025
Jun 30, 2023
($549.0K)
Aug 5, 2024
Q2
2025
Jun 30, 2023
($549.0K)
Nov 7, 2024
Q3
2025
Jun 30, 2023
($549.0K)
Feb 4, 2025
Q3
2024
Dec 31, 2022
$451.0K
Feb 5, 2024
Q3
2024
Sep 30, 2022
$1.31M
Feb 5, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
$7.98M
Feb 3, 2026
Q2
2025
Sep 30, 2025
$4.72M
Nov 6, 2025
Q1
2025
Jun 30, 2025
$3.06M
Aug 5, 2025
Q3
2025
Dec 31, 2024
$5.78M
Feb 3, 2026
Q2
2025
Sep 30, 2024
$3.51M
Nov 6, 2025
Q1
2025
Jun 30, 2024
$5.58M
Aug 5, 2025
Q3
2025
Dec 31, 2023
($67.0K)
Feb 4, 2025
Q2
2025
Sep 30, 2023
($60.0K)
Nov 7, 2024
Q1
2025
Jun 30, 2023
($664.0K)
Aug 5, 2024
Q3
2024
Dec 31, 2022
$3.40M
Feb 5, 2024
Q2
2024
Sep 30, 2022
$4.00M
Nov 6, 2023
Q1
2024
Jun 30, 2022
($4.59M)
Aug 3, 2023
Q3
2023
Dec 31, 2021
($2.51M)
Feb 6, 2023
Q2
2023
Sep 30, 2021
$4.20M
Nov 3, 2022
Q1
2023
Jun 30, 2021
$3.12M
Aug 4, 2022
Q3
2022
Dec 31, 2020
$22.0K
Feb 3, 2022
Q2
2022
Sep 30, 2020
$4.47M
Nov 4, 2021
Q1
2022
Jun 30, 2020
$3.57M
Aug 5, 2021
Q3
2020
Dec 31, 2019
($3.26M)
Feb 3, 2021
Q2
2020
Sep 30, 2019
$4.69M
Nov 5, 2020